RISK: Health, Safety & Environment (1990-2002)
Abstract
The FDA seems to acknowledge that sometimes different standards of proof for assessing drug efficacy should be used. Dr. Mendeloff thus proposes a methodology that might illuminate the FDA's decision-making and help better to assess its decisions.
Repository Citation
John M. Mendeloff, Decision Analysis and FDA Drug Review: A Proposal for Shadow Advisory Committees, 6 RISK 203 (1995).
Included in
Law Commons, Life Sciences Commons, Physical Sciences and Mathematics Commons, Social and Behavioral Sciences Commons